Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Tango Therapeutics (TNGX) Revenue (2020 - 2025)

Historic Revenue for Tango Therapeutics (TNGX) over the last 6 years, with Q3 2025 value amounting to $53.8 million.

  • Tango Therapeutics' Revenue rose 36360.82% to $53.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $66.5 million, marking a year-over-year increase of 5328.46%. This contributed to the annual value of $42.1 million for FY2024, which is 1517.23% up from last year.
  • Per Tango Therapeutics' latest filing, its Revenue stood at $53.8 million for Q3 2025, which was up 36360.82% from $3.2 million recorded in Q2 2025.
  • Over the past 5 years, Tango Therapeutics' Revenue peaked at $53.8 million during Q3 2025, and registered a low of $3.2 million during Q2 2025.
  • In the last 5 years, Tango Therapeutics' Revenue had a median value of $6.4 million in 2022 and averaged $10.7 million.
  • Examining YoY changes over the last 5 years, Tango Therapeutics' Revenue showed a top increase of 36360.82% in 2025 and a maximum decrease of 8399.5% in 2025.
  • Quarter analysis of 5 years shows Tango Therapeutics' Revenue stood at $5.7 million in 2021, then increased by 12.16% to $6.4 million in 2022, then decreased by 15.29% to $5.4 million in 2023, then fell by 24.19% to $4.1 million in 2024, then skyrocketed by 1207.04% to $53.8 million in 2025.
  • Its Revenue stands at $53.8 million for Q3 2025, versus $3.2 million for Q2 2025 and $5.4 million for Q1 2025.